Werner Sean
Chief Technology Officer
Werner Sean has filed 8 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Jul 21, 2026.
On the most recent filing, Werner Sean is listed as Chief Technology Officer at BIOLIFE SOLUTIONS INC. Inside the rolling window, Werner Sean reported no open-market purchases and 4 open-market sales totaling $15K in BLFS. The largest disclosed transaction in the window is a sale of 275 BLFS shares on Oct 20, 2025, worth $8K.
Companies traded
Other insiders at BLFS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$15K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Werner Sean made?
Werner Sean has filed 8 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Werner Sean trade?
Werner Sean has filed SEC Form 4 disclosures for 1 company, including BLFS.
When was Werner Sean's most recent SEC Form 4 filing?
Werner Sean's most recent SEC Form 4 filing on Tracefour is dated Jul 21, 2026.
What is Werner Sean's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Werner Sean is listed as Chief Technology Officer.
What is Werner Sean's total buy and sell value in the current window?
Inside the rolling retention window, Werner Sean bought $0 and sold $15K based on SEC Form 4 filings.
What was Werner Sean's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 275 BLFS shares on 2025-10-20, worth $8K, per SEC Form 4 filings.